NEW YORK (Reuters) - Vir Biotechnology priced its initial public offering (IPO) at $20 a share on Thursday, at the bottom end of expectations,...
from U.S. News - Civic https://ift.tt/2MzusiZ
from Yahoo News - Latest News & Headlines https://ift.tt/R2Yrilm
0 comments:
Post a Comment